About us
eGenesis is a biotechnology company that utilizes multiplex gene editing and genome engineering platform to transform solid organ and therapeutic cell transplantation for the treatment of serious disease. The company is committed to ending the global transplant shortage and transforming the treatment of organ failure. eGenesis is bringing that vision closer to reality with lead programs in kidney and islet cell transplantation.